(Q45746812)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10516725%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Effect of prior exposure to herpes simplex virus 1 on viral vector-mediated tumor therapy in immunocompetent mice (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10516725%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10516725%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

Chahlavi A

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10516725%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Todo T

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10516725%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Sundaresan P

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10516725%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

Martuza R

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10516725%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

publication date

1 October 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10516725%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10516725%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10516725%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10516725%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

1751-1758

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10516725%20AND%20SRC:MED&resulttype=core&format=json

In vivo behavior of genetically engineered herpes simplex viruses R7017 and R7020: construction and evaluation in rodents

1 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

Innate and acquired immunity to herpes simplex virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

Protection from primary infection and establishment of latency by vaccination with a herpes simplex virus type 1 recombinant deficient in the virion host shutoff (vhs) function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

Cellular Immune Response in Genital Herpes Simplex Virus Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

21 January 2018

Herpes simplex viruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

The immune response to herpes simplex virus: comparison of the specificity and relative titers of serum antibodies directed against viral polypeptides following primary herpes simplex virus type 1 infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

Demonstration of Exogenous Genital Reinfection with Herpes Simplex Virus Type 2 by Restriction Endonuclease Fingerprinting of Viral DNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

Prevention of cell-to-cell spread of herpes simplex virus by leukocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

Treatment of human breast cancer in a brain metastatic model by G207, a replication-competent multimutated herpes simplex virus 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

Contributions of antibody and T cell subsets to protection elicited by immunization with a replication-defective mutant of herpes simplex virus type 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

Experimental Infection of Inbred Mice with Herpes Simplex Virus Type 1. I. Investigation of Humoral and Cellular Immunity and of Interferon Induction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

Genetics of natural resistance to herpesvirus infections in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

Immunotherapy of malignancy by in vivo gene transfer into tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

Regression of Burkitt's lymphoma in association with measles infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

Viral oncolysis: increased immunogenicity of host cell antigen associated with influenza virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

New developments in the virus therapy of cancer: a historical review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

Pathogenesis of Herpes Simplex Virus in B Cell-suppressed Mice: the Relative Roles of Cell-mediated and Humoral Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

Pathogenesis of Herpes Simplex Virus in Congenitally Athymic Mice: the Relative Roles of Cell-mediated and Humoral Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

Passive immunization protects the mouse eye from damage after herpes simplex virus infection by limiting spread of virus in the nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

Experimental infection of inbred mice with herpes simplex virus. IV. Comparison of interferon production and natural killer cell activity in susceptible and resistant adult mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

Pre-existing herpes simplex virus 1 (HSV-1) immunity decreases, but does not abolish, gene transfer to experimental brain tumors by a HSV-1 vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

Correlation Between Low Natural Killing of Fibroblasts Infected with Herpes Simplex Virus Type 1 and Susceptibility to Herpesvirus Infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

Repeat administration of an adenovirus vector encoding cystic fibrosis transmembrane conductance regulator to the nasal epithelium of patients with cystic fibrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

Statistical approaches to experimental design and data analysis of in vivo studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

The mouse model and understanding immunity to herpes simplex virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

7 January 2021

Humoral immune response to HSV-1 and HSV-2 viral proteins in patients with primary genital herpes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

7 January 2021

Herpes simplex virus type 1-induced ribonucleotide reductase activity is dispensable for virus growth and DNA synthesis: isolation and characterization of an ICP6 lacZ insertion mutant

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

7 January 2021

Replication-defective mutants of herpes simplex virus (HSV) induce cellular immunity and protect against lethal HSV infection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

7 January 2021

Kinetics and genetics of herpes simplex virus-induced antibody formation in mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

7 January 2021

Immune response to herpes simplex virus infections: virus-specific antibodies in sera from patients with recurrent facial infections.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

7 January 2021

Immune response to recombinant capsid proteins of adenovirus in humans: antifiber and anti-penton base antibodies have a synergistic effect on neutralizing activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

7 January 2021

Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

7 January 2021

Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301003

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10516725%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

1 November 2019

1053468440

0 references

1 reference